No Data
Why Is Day One Biopharmaceuticals Inc. (DAWN) Among the Best Up and Coming Stocks to Buy According to Analysts?
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Day One Biopharmaceuticals Announces Leadership Transition
Express News | Day One Announces Retirement of DR. Samuel Blackman, Co-Founder and Head of Research & Development
JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas
Day One Biopharmaceuticals Insider Sold Shares Worth $456,223, According to a Recent SEC Filing
No Data
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
